Effects of copper on bone component in the femoral tissues of rats: Anabolic effect of zinc is weakened by copper

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 12, 2005, Pages 2296-2301

  Lai, Ying Ling ^a   Yamaguchi, Masayoshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Bone calcification; Bone resorption; Copper; Rat femur; Zinc

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL FACTOR; BONE RESORBING FACTOR; COPPER; COPPER SULFATE; CYCLOHEXIMIDE; PARATHYROID HORMONE; UNCLASSIFIED DRUG; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE METABOLISM; CALCIUM BONE LEVEL; CONTROLLED STUDY; DIAPHYSIS; DNA CONTENT; ENZYME ACTIVITY; FEMUR; MALE; METAPHYSIS; NONHUMAN; NUTRITION; PROTEIN SYNTHESIS; RAT; TISSUE CULTURE;

EID: 28744450581     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.28.2296     Document Type: Article

References (28)

1. Dollwet H. H. A., Sorenson J. R. J., Biol. Trace Elem. Res., 18, 39-48 (1998).
2. Rucker R. B., Murray J., Riggins R. S., Adv. Exp. Med. Biol., 86B, 619-648 (1997).
3. Stranse L. G., Hegenauer J., Saltman P., Cone R., Resnick D., J. Nutr., 116, 135-141 (1986).
4. Jonas J., Burns J., Abel E. W., Cresswell M. J., Strain J. J., Paterson C. R., Ann. Nutr. Metab., 37, 245-252 (1993).
5. Strause L., Saltman P., Glowacki J., Calcif. Tissue Int., 41, 145-150 (1987).
6. Opsahl W., Zeronian H., Ellison M., Lewis D., Rucker R. B., Riggins R. S., J. Nutr., 112, 708-716 (1982).
7. Kuo Y. M., Zhou B., Cosco D., Gitschier J., Proc. Natl. Acad. Sci. U.S.A., 98, 6836-6841 (2001).
8. Graham G. G., Cordano A., Johns Hopkins Med. J., 124, 139-150 (1969).
9. Yamaguchi M., Oishi H., Suketa Y., Biochem. Pharmacol., 36, 4007-4012 (1987).
10. Walter K., Schutt C., "Methods of Enzymatic Analysis," ed. by Bergmeyer H. U., Academic Press, New York, 1965, pp. 856-860.
11. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-273 (1951).
12. Flanagan B., Nichols G. J., J. Biol. Chem., 237, 3686-3692 (1962).
13. Ceriotti G., J. Biol. Chem., 214, 39-77 (1955).
14. Klein-Nulend J., Fall P. M., Raisz L. G., Endocrinology, 126, 223-227 (1990).
15. Canalis E., Centrella M., Bunch W., McCarthy T. L., J. Clin. Invest., 83, 60-65 (1989).
16. Majeska R. J., Wuthier R. E., Biochim. Biophys. Acta, 391, 51-60 (1975).
17. Ducy P., Zhang R., Geoffroy V., Ridall A. L., Karsenty G., Cell, 89, 747-754 (1997).
18. Rodrignez J. P., Rios S., Gonzalez M., J. Cell Biochem., 85, 92-100 (2002).
19. Wilson T., Katz J. M., Gray D. H., Calcif. Tissue Int., 33, 35 (1981).
20. Kishi S., Yamaguchi M., Biochem. Pharmacol., 48, 1225-1230 (1994).
21. Tanaka S., Nakajima I., Inoue J.-I., Oda H., Nakamura K., J. Bone Miner. Mertab., 21, 123-133 (2003).
22. Kagi T., Takata M., Miyahara T., Kozuka H., Koizumi F., Toxicol. Lett., 55, 255-262 (1991).
23. Yamaguchi M., Oishi H., Suketa Y., Biochem. Pharmacol., 37, 4075-4080 (1988).
24. Hashizume M., Yamaguchi M., Mol. Cell. Biochem., 122, 59-64 (1993).
25. Yamaguchi M., Hashizume M., Mol. Cell. Biochem., 136, 163-169 (1994).
26. Yamaguchi M., Kishi S., Hashizume M., Peptides, 15, 1367-1371 (1994).
27. Yamaguchi M., Segawa Y., Shimokawa N., Tsuzuike N., Tagashira E., Pharmacology, 45, 292-300 (1992).
28. Yamaguchi M., Uchiyama S., Int. J. Mol. Med., 12, 755-761 (2003).